AMERICAN pharmaceutical company Eli Lilly has invested US$1bn into the expansion of its manufacturing site in Limerick, ...

This additional investment is part of the most ambitious manufacturing expansion agenda in the company's history. Since 2020, ...

Lilly has announced a significant expansion of its manufacturing presence in Ireland, with a $1bn investment earmarked for ...

With a new investment in its two manufacturing sites in Ireland, Eli Lilly continues implementing the largest expansion ...

US pharmaceutical giant Eli Lilly has announced plans for a $1bn (€907m) expansion of its Limerick manufacturing site. This ...

Eli Lilly and Company (NYSE:LLY) on Thursday announced a $1.8 billion investment to expand its manufacturing operations in Ireland. This decision will enhance the production of biologic active ...

Eli Lilly said it will spend $1.8 billion to boost production in Ireland of its popular diabetes and weight-loss drugs, along with ingredients for its recently approved Alzheimer’s treatment, Kisunla.

Limerick is set to further cement its status as a key hub for innovation and life sciences following the announcement of a $1 billion (€927 million) investment by pharmaceutical giant Eli Lilly.

Eli Lilly and Company (NYSE: LLY) today announced a $1 billion expansion of its Limerick, Ireland, manufacturing site to ...

Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely popular obesity drug and a newly approved treatment for Alzheimer's, the drugmaker said ...

The facility at a business park in Raheen, Limerick, was first announced in 2022 and this is the second time that Lilly has ...

Pharmaceutical company Eli Lilly has announced a further €927 million investment at its facility at Raheen in Limerick, creating a further 150 jobs there.